Rxivist logo

Author: Carl Graham

  • Most recently observed institution: King's College London

Rankings

  • All-time downloads: 127,430 (rank: 1,141 )
  • Categories:
    • epidemiology: 1,571 (rank: 9,228 (tie) )
    • hematology: 1,403 (rank: 267 (tie) )
    • immunology: 5,965 (rank: 2,211 )
    • infectious diseases: 112,546 (rank: 444 (tie) )
    • microbiology: 278 (rank: 55,774 (tie) )
    • oncology: 5,667 (rank: 31 (tie) )

Downloads per author, site-wide

Preprints

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

infectious diseases more details view paper
  • Downloaded 93,826 times
  • Download rankings, all-time:
    • Site-wide: 75
    • In infectious diseases: 27
  • Year to date:
    • Site-wide: 211
  • Since beginning of last month:
    • Site-wide: 578

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

infectious diseases more details view paper
  • Downloaded 6,606 times
  • Download rankings, all-time:
    • Site-wide: 1,929
    • In infectious diseases: 546
  • Year to date:
    • Site-wide: 9,890
  • Since beginning of last month:
    • Site-wide: 17,182

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

oncology more details view paper
  • Downloaded 5,667 times
  • Download rankings, all-time:
    • Site-wide: 2,379
    • In oncology: 2
  • Year to date:
    • Site-wide: 7,639
  • Since beginning of last month:
    • Site-wide: 7,996

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

infectious diseases more details view paper
  • Downloaded 5,557 times
  • Download rankings, all-time:
    • Site-wide: 2,443
    • In infectious diseases: 644
  • Year to date:
    • Site-wide: 68,967
  • Since beginning of last month:
    • Site-wide: 18,207

SARS-CoV-2 recruits a haem metabolite to evade antibody immunity

infectious diseases more details view paper
  • Downloaded 4,117 times
  • Download rankings, all-time:
    • Site-wide: 3,686
    • In infectious diseases: 830
  • Year to date:
    • Site-wide: 26,838
  • Since beginning of last month:
    • Site-wide: 17,539

The impact of Spike mutations on SARS-CoV-2 neutralization

immunology more details view paper
  • Downloaded 2,839 times
  • Download rankings, all-time:
    • Site-wide: 6,236
    • In immunology: 237
  • Year to date:
    • Site-wide: 32,164
  • Since beginning of last month:
    • Site-wide: 30,895

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike

immunology more details view paper
  • Downloaded 1,688 times
  • Download rankings, all-time:
    • Site-wide: 13,434
    • In immunology: 471
  • Year to date:
    • Site-wide: 1,848
  • Since beginning of last month:
    • Site-wide: 11,995

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England

epidemiology more details view paper
  • Downloaded 1,571 times
  • Download rankings, all-time:
    • Site-wide: 14,953
    • In epidemiology: 1,074
  • Year to date:
    • Site-wide: 96,105
  • Since beginning of last month:
    • Site-wide: 56,544

ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies

immunology more details view paper
  • Downloaded 973 times
  • Download rankings, all-time:
    • Site-wide: 30,852
    • In immunology: 1,045
  • Year to date:
    • Site-wide: 6,821
  • Since beginning of last month:
    • Site-wide: 10,020

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

infectious diseases more details view paper
  • Downloaded 910 times
  • Download rankings, all-time:
    • Site-wide: 34,149
    • In infectious diseases: 2,859
  • Year to date:
    • Site-wide: 24,516
  • Since beginning of last month:
    • Site-wide: 19,860

Broad neutralization of SARS-CoV-2 variants, including omicron, following breakthrough infection with delta in COVID-19 vaccinated individuals

infectious diseases more details view paper
  • Downloaded 789 times
  • Download rankings, all-time:
    • Site-wide: 41,928
    • In infectious diseases: 3,177
  • Year to date:
    • Site-wide: 1,058
  • Since beginning of last month:
    • Site-wide: 427

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot service

infectious diseases more details view paper
  • Downloaded 741 times
  • Download rankings, all-time:
    • Site-wide: 45,876
    • In infectious diseases: 3,326
  • Year to date:
    • Site-wide: 51,902
  • Since beginning of last month:
    • Site-wide: 72,010

Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

hematology more details view paper
  • Downloaded 733 times
  • Download rankings, all-time:
    • Site-wide: 46,581
    • In hematology: 43
  • Year to date:
    • Site-wide: 47,770
  • Since beginning of last month:
    • Site-wide: 42,310

Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML

hematology more details view paper
  • Downloaded 670 times
  • Download rankings, all-time:
    • Site-wide: 52,745
    • In hematology: 53
  • Year to date:
    • Site-wide: 63,593
  • Since beginning of last month:
    • Site-wide: 45,544

ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants

immunology more details view paper
  • Downloaded 465 times
  • Download rankings, all-time:
    • Site-wide: 82,264
    • In immunology: 2,519
  • Year to date:
    • Site-wide: 15,721
  • Since beginning of last month:
    • Site-wide: 26,195

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

microbiology more details view paper
  • Downloaded 278 times
  • Download rankings, all-time:
    • Site-wide: 126,733
    • In microbiology: 9,068
  • Year to date:
    • Site-wide: 49,114
  • Since beginning of last month:
    • Site-wide: 91,573

PanLingua

News